Trading Sections

Record Backlog Supports Operational Performance of Argan: JP Morgan Raises its Rating after the Earnings and Sees 35% Upside Potential.

The energy transition and the rapid increase in data centers create a massive and structural demand for...

Corcept Therapeutics: FDA Approval as a Gamechanger - Oncology Breakthrough as a Price Driver

FDA Approval as a Historic Milestone For Corcept Therapeutics (CORT) , late March 2026 marks a pivotal...

Key Position in the US Defense and Aerospace Market: Karman Increases Revenue by 37% in 2025 and Raises Guidance

Karman Holdings (KRMN) remains a strong stock in the Defense & Space sector. The company has successfully...

Roblox: Underrated Earnings Potential and Why Bank of America Sets a $165 Price Target!

March 2026 is all about strategic development and strengthening its own ecosystem for Roblox Corporation...

Firefly Aerospace: Orbital Opportunities - Tech Transformation Accelerates Firefly's Space Business.

Jason Kim, CEO of Firefly Aerospace (FLY) , described 2025 as a "transformative year," marked by a historic...

Nebius Focuses on Vertical Integration and AI Infrastructure. Bank of America Sees a Huge Opportunity and About 30% Upside Potential.

Nebius (NBIS) is rapidly building a fully integrated full-stack cloud platform with massive capital...

Hut 8 Mining: Arete Research Sees 177% Price Potential!

The recent rating by the research firm Arete Research on March 23 marks a significant vote of confidence...

The Demand for LNG and Data Centers Constitutes a Tailwind for Powell Industries.

The market is easing a bit following Donald Trump's tweet. The stock of Powell Industries (POWL) is...

Larimar Therapeutics: Analysts Predict Massive Upside Potential of Up to 430%

Regulatory Breakthrough and Strategic Milestones Larimar Therapeutics (LRMR) (still listed under...

Intuitive Machines: The Merger Creates an Infrastructure Giant in Orbit. Revenue Forecast Rises to $1 Billion in 2026.

It was on Thursday (March 19th) that the books of Intuitive Machines (LUNR) were last presented before...

Olema Pharmaceuticals: Billion Market in Sight – Why Analysts See Huge Price Potentials Now

Operational Progress and the Path to Commercial Phase Olema Pharmaceuticals (OLMA) is in a critical...

Arcturus Therapeutics Holdings

Arcturus Therapeutics: B. Riley Praises the Modified Lipid-Based RNA Platform and Sees Approximately 230% Price Potential

Revolutionary mRNA Technology for Rare Genetic Defects Arcturus Therapeutics (ARCT) positions itself...

No AI Without Power: Data Centers’ Energy Consumption is Skyrocketing. NRG Energy Receives Strong Analyst Support with a Price Target of $232 (+48%)

Without electricity, there is no intelligence. A ChatGPT query consumes about ten times more energy than...

Ocugen: On the Brink of Commercial Breakthrough with Groundbreaking Gene Therapies and Strong Analyst Support

Ocugen Inc. (OCGN) (i.) is on the brink of fundamentally revolutionizing the treatment of serious eye...

Elbit Systems: Record Orders Despite Local Production Hurdles. The Israeli Defense Contractor is Greatly Benefiting from the Global Demand for High-Tech Weapons.

Elbit Systems: Record orders despite local production hurdles. The Israeli defense contractor is greatly...

Exelon: The Investment Plan with a Focus on Transmission Lines Dominated the Latest Earnings. The Stock is now Facing a big-Picture Breakout.

The ability of utility Exelon (EXC) to supply nearly eleven million customers during a stress test in...

LifeMD: The Clever Portfolio Play in the GLP-1 Boom – Why Wall Street is Celebrating the {[Telemedicine Star]} Now

LifeMD(LFMD) is a rapidly growing provider in the field of virtual primary care and telemedicine in...

Warrior Met Coal: Successful Test of the MA150. Will the Breakout from the Bull Flag Follow?

Coal stocks have been performing positively in recent days. Due to outages in Qatar and risks in the...

Oracle: Guggenheim Sees the Stock as "Best Idea" in the Entire Software Sector with a Price Potential of Approximately 155%!

Oracle (ORCL) is positioning itself as the central nervous system of modern enterprises and offers...

Oruka Therapeutics: Revolution in Dermatology – Wall Street Sees Up to 119% Price Potential!

Revolutionizing Dermatology Through Extended Half-Lives Oruka Therapeutics (ORKA) positions itself...

Zalando SE: Goldman Sachs Praises Developments in Q4 and the Announced Share Buyback Program - Expert Sees 93% Price Potential

Europe's Leading Ecosystem for Fashion and Lifestyle Zalando SE no longer sees itself merely as a...